{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:48:56Z","timestamp":1789728536453,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIHR Doctoral Fellowship","award":["NIHR302309"],"award-info":[{"award-number":["NIHR302309"]}]},{"DOI":"10.13039\/100013927","name":"National MPS Society","doi-asserted-by":"crossref","award":["CSAC-KEN.MFT.202105"],"award-info":[{"award-number":["CSAC-KEN.MFT.202105"]}],"id":[{"id":"10.13039\/100013927","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mucopolysaccharidosis (MPS) type IVA is a rare lysosomal storage disorder caused by aberrations of the N-acetyl-galactosamine-6-sulfatase (GALNS) enzyme. MPS IVA is associated with a wide gamut of respiratory and airway disorders that manifest in a continuum of severity. In individuals exhibiting severe phenotypic expression, terminal stages of the disease frequently culminate in life-threatening, critical airway obstruction. These manifestations of end-stage disease are engendered by an insidious progression of multi-level airway pathologies, comprising of tracheomalacia, stenosis, tortuosity and 'buckling'. Historically, the management of end-stage airway disease has predominantly leaned towards palliative modalities. However, contemporary literature has posited that the potential benefits of tracheal resection with aortopexy, performed under cardiopulmonary bypass (CPB), may offer a promising therapeutic option. In this context, we report on outcomes from patients undergoing a novel approach to tracheal resection that is combined with manubrial resection, leading to improved airway calibre, obviating the requisition for CPB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this study, seven patients with severe MPS IVA exhibited clinical symptoms and radiological evidence indicative of advanced airway obstruction. All patients had a tracheal resection with a partial upper manubriectomy via transcervical approach, which did not require CPB. The surgical cohort consisted of 5 females and 2 males, the median age was 16 years (range 11-19) and the median height was 105.6cm (range 96.4-113.4). Postoperatively, significant improvements were seen in forced expiratory volume in 1 second (FEV1), with a mean increase of 0.68 litres (95% CI: 0.45-0.91; SD: 0.20). Notably, other spirometry variables also showed meaningful improvements, providing evidence of positive treatment effects. Furthermore, there were no major long-term complications, and the procedure resulted in a significant enhancement in patient-reported domains using PedsQL (version 4.0).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study represents the largest case series to date, on tracheal resection in patients with severe MPS IVA. Our findings demonstrate the effectiveness of the transcervical approach with partial manubriectomy for improving respiratory function and quality of life for individuals with advanced airway obstruction. Tracheal resection presents a promising treatment modality for severe cases of MPS IVA. Successful outcomes rely on meticulous multidisciplinary assessment, judicious decision-making, and appropriate timing of tracheal surgery. Further research and long-term follow-up studies are warranted to validate the long-term efficacy and safety of this approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-024-03253-3","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T03:02:32Z","timestamp":1721617352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel approach for tracheal resection in Morquio a syndrome with end-stage critical airway obstruction: a UK case series"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0348-6865","authenticated-orcid":false,"given":"Johnny","family":"Kenth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Maughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin R","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasleen","family":"Gabrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"Rouhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olumide K","family":"Ogunbiyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagarajan","family":"Muthialu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain A","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"3253_CR1","first-page":"55","volume":"32","author":"A Broomfield","year":"2019","unstructured":"Broomfield A, Kenth J, Bruce IA, Tan HL, Wilkinson S. Respiratory complications of metabolic disease in the paediatric population: a review of presentation, diagnosis and therapeutic options. Paediatr Respir Rev. 2019;32:55.","journal-title":"Paediatr Respir Rev."},{"key":"3253_CR2","unstructured":"Jones S, Wynn R. Mucopolysaccharidoses: Clinical features and diagnosis - UpToDate. Available from: https:\/\/www.uptodate.com\/contents\/mucopolysaccharidoses-clinical-features-and-diagnosis?search=MPS%20IV&source=search_result&selectedTitle=1~15&usage_type=default&display_rank=1#H10. Cited 2018 Sep 1."},{"key":"3253_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgmr.2017.11.005","volume":"14","author":"C Doherty","year":"2018","unstructured":"Doherty C, Averill LW, Theroux M, Mackenzie WG, Pizarro C, Mason RW, et al. Natural history of Morquio A patient with tracheal obstruction from birth to death. Mol Genet Metab Rep. 2018;14:59\u201367.","journal-title":"Mol Genet Metab Rep."},{"key":"3253_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13023-019-1074-9","volume":"14","author":"MU Akyol","year":"2019","unstructured":"Akyol MU, Alden TD, Amartino H, Ashworth J, Belani K, Berger KI, et al. Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance. Orphanet J Rare Dis. 2019;14:137.","journal-title":"Orphanet J Rare Dis"},{"key":"3253_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymgme.2013.01.021","volume":"109","author":"P Harmatz","year":"2013","unstructured":"Harmatz P, Mengel KE, Giugliani R, Valayannopoulos V, Lin S-P, Parini R, et al. The Morquio A Clinical Assessment Program: Baseline results illustrating progressive, multisystemic clinical impairments in Morquio a subjects. Mol Genet Metab. 2013;109:54\u201361.","journal-title":"Mol Genet Metab"},{"key":"3253_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ymgme.2015.09.007","volume":"117","author":"S Tomatsu","year":"2016","unstructured":"Tomatsu S, Averill LW, Sawamoto K, Mackenzie WG, Bober MB, Pizarro C, et al. Obstructive airway in Morquio a syndrome, the past, the present and the future. Mol Genet Metab. 2016;117:150\u20136.","journal-title":"Mol Genet Metab"},{"key":"3253_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/adc.72.3.263","volume":"72","author":"JE Wraith","year":"1995","unstructured":"Wraith JE. The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child. 1995;72:263\u20137.","journal-title":"Arch Dis Child."},{"key":"3253_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10545-012-9459-0","volume":"36","author":"CJ Hendriksz","year":"2013","unstructured":"Hendriksz CJ, Lawrence R, Mc Ardle C, Wright E, Al-Jawad M, Berger KI, et al. Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA. J Inherit Metab Dis. 2013;36:309\u201322.","journal-title":"J Inherit Metab Dis"},{"key":"3253_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/thorax.58.5.458","volume":"58","author":"PP Walker","year":"2003","unstructured":"Walker PP, Rose E, Williams JG. Upper airways abnormalities and tracheal problems in Morquio\u2019s disease. Thorax. 2003;58:458\u20139.","journal-title":"Thorax."},{"key":"3253_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10545-012-9563-1","volume":"36","author":"R Walker","year":"2013","unstructured":"Walker R, Belani KG, Braunlin EA, Bruce IA, Hack H, Harmatz PR, et al. Anaesthesia and airway management in mucopolysaccharidosis. J Inherit Metab Dis. 2013;36:211\u20139.","journal-title":"J Inherit Metab Dis."},{"key":"3253_CR11","doi-asserted-by":"crossref","first-page":"100487","DOI":"10.1016\/j.ymgmr.2019.100487","volume":"20","author":"JJ Kenth","year":"2019","unstructured":"Kenth JJ, Thompson G, Fullwood C, Wilkinson S, Jones S, Bruce IA. The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: a longitudinal analysis. Mol Genet Metab Rep. 2019;20:100487.","journal-title":"Mol Genet Metab Rep"},{"key":"3253_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13023-021-01675-x","volume":"16","author":"M Cleary","year":"2021","unstructured":"Cleary M, Davison J, Gould R, Geberhiwot T, Hughes D, Mercer J, et al. Impact of long-term elosulfase alfa treatment on clinical and patient-reported outcomes in patients with mucopolysaccharidosis type IVA: results from a Managed Access Agreement in England. Orphanet J Rare Dis. 2021;16:38.","journal-title":"Orphanet J Rare Dis"},{"key":"3253_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","volume":"30","author":"AM Monta\u00f1o","year":"2007","unstructured":"Monta\u00f1o AM, Tomatsu S, Gottesman GS, Smith M, Orii T. International Morquio a registry: clinical manifestation and natural course of Morquio a disease. J Inherit Metab Dis. 2007;30:165\u201374.","journal-title":"J Inherit Metab Dis."},{"key":"3253_CR14","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1016\/j.athoracsur.2016.02.113","volume":"102","author":"C Pizarro","year":"2016","unstructured":"Pizarro C, Davies RR, Theroux M, Spurrier EA, Averill LW, Tomatsu S. Surgical reconstruction for severe tracheal obstruction in morquio a syndrome. Ann Thorac Surg. 2016;102:e329-331.","journal-title":"Ann Thorac Surg"},{"key":"3253_CR15","doi-asserted-by":"publisher","first-page":"109721","DOI":"10.1016\/j.ijporl.2019.109721","volume":"128","author":"P Kiessling","year":"2020","unstructured":"Kiessling P, Stans AA, Dearani JA, Boesch RP, Fogelson JL, Matsumoto JM, et al. Coordinated approach to spinal and tracheal reconstruction in a patient with morquio syndrome. Int J Pediatr Otorhinolaryngol. 2020;128:109721.","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"3253_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/EJA.0000000000001109","volume":"37","author":"H Hack","year":"2020","unstructured":"Hack H, Chapman I, Finucane K, Barber C. Anaesthesia and orphan disease: tracheal reconstruction in two children with Morquio disease. Eur J Anaesthesiol. 2020;37:132\u20137.","journal-title":"Eur J Anaesthesiol."},{"key":"3253_CR17","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/lary.22355","volume":"121","author":"D Valencia","year":"2011","unstructured":"Valencia D, Overman D, Tibesar R, Lander T, Moga F, Sidman J. Surgical management of distal tracheal stenosis in children. Laryngoscope. 2011;121:2665\u201371.","journal-title":"Laryngoscope."},{"key":"3253_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.suc.2009.05.006","volume":"89","author":"G Ailawadi","year":"2009","unstructured":"Ailawadi G, Zacour RK. Cardiopulmonary bypass\/extracorporeal membrane oxygenation\/left heart bypass: indications, techniques, and complications. Surg Clin North Am. 2009;89:781\u201396.","journal-title":"Surg Clin North Am"},{"key":"3253_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/00034894211032778","volume":"131","author":"Y-H Lee","year":"2022","unstructured":"Lee Y-H, Hsieh L-C, Su C-H, Lin H-Y, Lin S-P, Lee K-S. Airway management of the deformed trachea using T-Tube Stents in Patients with Mucopolysaccharidosis Type IVA. Ann Otol Rhinol Laryngol. 2022;131:562\u20136.","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"3253_CR20","first-page":"e7976780","volume":"2023","author":"C Frauenfelder","year":"2023","unstructured":"Frauenfelder C, Maughan E, Kenth J, Nandi R, Jones S, Walker R, et al. Tracheal resection for critical airway obstruction in morquio a syndrome. Case Rep Pediatr. 2023;2023:e7976780.","journal-title":"Case Rep Pediatr"},{"key":"3253_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/A:1014836921812","volume":"25","author":"JW Varni","year":"2002","unstructured":"Varni JW, Seid M, Knight TS, Uzark K, Szer IS. The PedsQL 4.0 Generic Core Scales: sensitivity, responsiveness, and impact on clinical decision-making. J Behav Med. 2002;25:175\u201393.","journal-title":"J Behav Med"},{"key":"3253_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/j.1365-2044.1984.tb08932.x","volume":"39","author":"RS Cormack","year":"1984","unstructured":"Cormack RS, Lehane J. Difficult tracheal intubation in obstetrics. Anaesthesia. 1984;39:1105\u201311.","journal-title":"Anaesthesia."},{"key":"3253_CR23","unstructured":"Elosulfase alfa for treating mucopolysaccharidosis type IVa | Guidance and guidelines | NICE. 2015. Available from: https:\/\/www.nice.org.uk\/guidance\/hst2. Cited 2018 Dec 16."},{"key":"3253_CR24","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1517\/21678707.2015.1086640","volume":"3","author":"S Tomatsu","year":"2015","unstructured":"Tomatsu S, Sawamoto K, Shimada T, Bober MB, Kubaski F, Yasuda E, et al. Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations. Expert Opin Orphan Drugs. 2015;3:1279\u201390.","journal-title":"Expert Opin Orphan Drugs"},{"key":"3253_CR25","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3390\/ijms21072515","volume":"21","author":"S Fecarotta","year":"2020","unstructured":"Fecarotta S, Tarallo A, Damiano C, Minopoli N, Parenti G. Pathogenesis of Mucopolysaccharidoses, an Update. Int J Mol Sci. 2020;21:2515.","journal-title":"Int J Mol Sci."},{"key":"3253_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12890-019-0793-y","volume":"19","author":"X Xiong","year":"2019","unstructured":"Xiong X, Xu L, Fan L, Cheng D, Zheng B. Long-term follow-up of self-expandable metallic stents in benign tracheobronchial stenosis: a retrospective study. BMC Pulmonary Med. 2019;19:33.","journal-title":"BMC Pulmonary Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03253-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03253-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03253-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T09:57:04Z","timestamp":1732442224000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03253-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3253"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03253-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3356306\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"assertion":[{"value":"1 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Great Ormand Street Ethics Committee approval was obtained before undertaking the surgical procedure. All patients provided consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided consent to publish clinical data, imaging and histopathology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest or competing interests relevant to this article to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"274"}}